Karin Herrera
Hoofd Techniek/Wetenschap/O&O bij COMPASS THERAPEUTICS, INC.
Profiel
Karin Herrera is currently the Vice President & Head-Clinical Operations at Compass Therapeutics, Inc. She previously worked as the Vice President-Clinical Operations at Kadmon Corp.
LLC.
Ms. Herrera completed her undergraduate degree at Assumption College.
Actieve functies van Karin Herrera
| Bedrijven | Functie | Begin |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
Eerdere bekende functies van Karin Herrera
| Bedrijven | Functie | Einde |
|---|---|---|
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Opleiding van Karin Herrera
| Assumption College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
